Bristol Myers - Celgene CVRPreferred / convertible

13F holders, Q1 2024 (March 31)
20holders
1famous investor
$11.14avg. 13F price*

At the end of Q1 2024, 20 institutions reported holding Bristol Myers - Celgene CVR in their 13F filings. The largest holders were FourWorld Capital Management LLC ($5.4M), Transcend Capital Advisors, LLC ($6K) and DAVENPORT & Co LLC ($5K). One famous investor held it Ken Griffin ( of Citadel Advisors's portfolio).

Company
Bristol Myers - Celgene CVR
CUSIP
110122140
Latest filing quarter
Q2 2026

History

Number of 13F holders

0510152025 Q1 2024: 20Q1 2024Q2 2024: 18Q2 2024Q3 2024: 21Q3 2024Q4 2024: 20Q4 2024Q1 2025: 20Q1 2025Q2 2025: 24Q2 2025Q3 2025: 22Q3 2025Q4 2025: 18Q4 2025Q1 2026: 17Q1 2026Q2 2026: 15Q2 2026

Total Exit/New Position Q1 2024

InstitutionsTotal Value
New Positions3$1K
Exits1$1K

Ownership 20 holders

FourWorld Capital Management LLC — No change 100,000 $5.4M
Transcend Capital Advisors, LLC — No change 117,775 $6K
DAVENPORT & Co LLC — No change 83,970 $5K
Susquehanna International Group, LLP — Reduce -12.7% 78,058 $4K
Citadel Advisors — Reduce -1.8% 38,034 $2K
Captrust Financial Advisors — New 20,498 $1K
Fifth Third Bancorp — No change 20,000 $1K
Private Advisor Group, LLC — No change 15,000 $825
Trivium Point Advisory, LLC — No change 10,000 $550
Bank of America Corp. — Add +12.2% 1,838 $101
Northwestern Mutual Wealth Management Co. — No change 242 $13
International Assets Investment Management, LLC — New 175 $10
Rothschild Investment LLC — No change 166 $9
Morgan Stanley — No change 164 $9
Oakworth Capital, Inc. — No change 125 $7
Wells Fargo & Company — Reduce -9.7% 28 $2
UBS Group AG — Reduce -98.5% 30 $2
JPMorgan Chase & Co. — No change 23 $1
Atlantic Edge Private Wealth Management, LLC — New 16 $1
Royal Bank of Canada — No change 2,475 $0

"% of holder's portfolio" is BRISTOL MYERS - CELGENE CVR's weight in each manager's 13F, not the share of Bristol Myers - Celgene CVR the manager owns.